Utah Medical Products, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Utah Medical Products, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 41.6 times. Higher than almost all Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
$124Over the last 3 years, every $100 of reported profit came with $124 of operating cash.
Lower than 69% of Healthcare companies in United States.
Self-Funding Ratio
41.6×Over the last 3 years its own operating cash covered its investment spending (capex) 41.6 times.
Higher than almost all Healthcare companies in United States.
Cash Locked Ratio
$30For every $100 of sales, $30 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $24 tied up three years earlier.
More money tied up than 65% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 26%
Sales fell 26% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-26% / -1%In 3 years sales changed by -26% while total assets changed by -1%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
+36%Cash, after subtracting all debt, equals 36% of its market value (net cash).
Higher than 72% of Healthcare companies in United States.
Tangible Assets Ratio
88%Of every $100 the company owns, $88 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 59% of Healthcare companies in United States.
Tangible Net Worth Ratio
88%Of every $100 of net worth, $88 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 70% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Utah Medical Products, Inc. owes $0.02 for every $1 it owns. Net profit fell 19% in the year to Dec 2025, and shrank 12% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
22.9Investors pay $22.9 for every $1 of Utah Medical Products, Inc.'s yearly profit, lower than 58% of Healthcare companies in United States.
P/B ratio
1.95The share price is 1.95 times Utah Medical Products, Inc.'s book value per share, lower than 60% of Healthcare companies in United States.
Market cap
$238 MThe total market value of all of Utah Medical Products, Inc.'s shares at today's price (share price × number of shares), smaller than 56% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$122 MWhat Utah Medical Products, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$38.45Net worth divided by the number of shares. The share price of $75.06 is 2.0 times this, which is the P/B above.
Return on equity (ROE)
8.8%Utah Medical Products, Inc. earned 8.8% on its shareholders' money over the last year, higher than 82% of Healthcare companies in United States.
Owes vs Owns
0.02×Utah Medical Products, Inc. owes $0.02 for every $1 it owns (low), lower than almost all Healthcare companies in United States.
Dividend yield
1.66%Utah Medical Products, Inc. pays 1.66% of its share price as dividends a year, higher than 68% of dividend-paying Healthcare companies in United States.
Revenue growth
-6%Revenue fell 6% in the year to Dec 2025, and shrank 10% a year on average over 3 years.
Profit growth
-19%Net profit fell 19% in the year to Dec 2025, and shrank 12% a year on average over 3 years.
Profit margin
29.3%Utah Medical Products, Inc. keeps $29 of every $100 of revenue as net profit.
Cash quality
1.3×Cash from Utah Medical Products, Inc.'s business was 1.3× its reported profit in the year to Dec 2025 — its profit turned into cash.
Cash vs debt
Net cashUtah Medical Products, Inc. held $86 M more cash than debt (net cash) at Dec 2025.
Questions
What is Utah Medical Products, Inc.'s P/E ratio?
Investors pay $22.9 for every $1 of Utah Medical Products, Inc.'s yearly profit, lower than 58% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Utah Medical Products, Inc.: $238 M ÷ $122 M (30 Jun 2026) = 2.0.
What is Utah Medical Products, Inc.'s return on equity?
Utah Medical Products, Inc. earned 8.8% on its shareholders' money over the last year, higher than 82% of Healthcare companies in United States.
How much does Utah Medical Products, Inc. owe compared with what it owns?
Utah Medical Products, Inc. owes $0.02 for every $1 it owns (low), lower than almost all Healthcare companies in United States.
Does Utah Medical Products, Inc. pay a dividend?
Yes. Utah Medical Products, Inc. pays 1.66% of its share price as dividends a year, higher than 68% of dividend-paying Healthcare companies in United States.
Is Utah Medical Products, Inc.'s revenue growing?
Revenue fell 6% in the year to Dec 2025, and shrank 10% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.